In 2023, the import value of penicillins or streptomycins in dosage forms to Brazil stood at approximately 80 million USD. From 2024, the forecasted data shows a consistent upward trend. The year-on-year growth from 2024 to 2028 suggests a gradually increasing rate, with the values for 2024 and 2025 expected to grow by around 2.9% each year, while the values for 2025 to 2026, 2026 to 2027, and 2027 to 2028 indicate continued growth by approximately 2.7% annually. The forecasted compound annual growth rate (CAGR) over this five-year period is around 2.8%.

Key future trends to watch for include:

Potential impacts of global pharmaceutical supply chains on import volumes.
Influence of Brazil's healthcare policy changes on demand for imported antibiotics.
Technological advancements and production increases in domestic capabilities which might affect import levels.